Denali Therapeutics Inc (DNLI) - Kapitalisasi marang bathi
Denali Therapeutics (DNLI) is developing a unique method for drug delivery into the brain by collaborating with Western leaders under the protection of humanitarian status. The issuer's P/E ratio demonstrates the investment payback period, while the -9.60 metric indicates the status of the current valuation. However, dependence on Asian supplies and export restrictions could slow down global clinical trials of the software.
Rincian metrik komprehensif lan analitis denalitherapeutics.com (DNLI)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Denali Therapeutics|DNLI - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Denali Therapeutics Inc.|DNLI - Gunggung utang perusahaan|Rasio utang marang aset resik Denali Corp|DNLI - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Denali Therapeutics|Rasio jangkoan perantara denalitherapeutics.com
- rincian asil keuangan lan kelipatan valuasi:
DNLI - Bathi resik|Bathi resik sing dikarepake Denali Therapeutics|DNLI - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Denali Therapeutics Inc|DNLI - Pangali PEG|Pangali EV/EBITDA Denali Therapeutics Inc|DNLI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Denali Therapeutics|DNLI - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan denalitherapeutics.com|DNLI - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Denali Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Analisis umum perusahaan:Denali Therapeutics Inc - DNLI
Denali Therapeutics (DNLI) is building long-term patent potential through the development of innovative brain drug delivery methods, which the market is currently pricing into the stock. By analyzing the company's current P/E ratio, investors assess the relationship between market capitalization and actual earnings, allowing for a real-time assessment of the cost of capital and liquidity risks within the highly capital-intensive biotechnology sector.
Perusahaan pesaing
Rasio rega marang bathi BIIB|Pangali P/E NBIX|Regencell (RGC) - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi axsome.com AXSM|Pangali P/E ACADIA Pharmaceuticals ACAD|XENE - Rasio rega marang bathi|Periode bali modal bisnis Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Rasio rega marang bathi|CPRX (Catalyst Pharmaceuticals) - Rasio rega marang bathi|Rasio rega marang bathi Harmony Biosciences Holdings, Inc.|Rasio rega marang bathi BHVN|Koefisien rega marang bathi AMLX (Amylyx Pharmaceuticals, Inc.)|Rasio rega pasar marang bathi resik TRVI|Rasio rega marang bathi Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Rasio rega marang bathi|CBLL: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PRTA (prothena.com)|Alector, Inc. (ALEC) - Rasio rega marang bathi|Pangali rega marang bathi ANNX|Rasio rega marang bathi Omeros Corp.|Neurogene Therapeutics (NGNE) - Periode bali modal bisnis|Pangali P/E ACIU|VYGR (Voyager Therapeutics) - Nilai perusahaan marang bathi resik|Pangali P/E NMRA (neumoratx.com)|SCLX: Pangali rega marang bathi|TVGN - Rasio rega marang bathi|Kapitalisasi marang bathi Alpha Cognition Inc.|CGTX: Pangali P/E|inhibikase.com (IKT) - Pangali P/E|Rasio rega marang bathi Cassava Sciences Inc|ASRT - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi Coya (COYA)|Pangali P/E VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Koefisien rega marang bathi|Periode bali modal bisnis Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - Pangali P/E|Periode bali modal bisnis alteritytherapeutics.com ATHE|CLNN: Pangali P/E|Kapitalisasi marang bathi PepGen Corp (PEPG)|Rasio rega marang bathi Jupiter Neurosciences, Inc.|RLMD: Nilai perusahaan marang bathi resik|Pangali P/E ANVS|Koefisien rega marang bathi Grace Tx GRCE|Rasio rega marang bathi Firefly Neuroscience, Inc AIFF|KLTO: Pangali rega marang bathi|NRSN - Rasio rega marang bathi|RVPH: Rasio rega marang bathi|MTVA (MetaVia Inc.) - Koefisien rega marang bathi|NeurAxis Inc. (NRXS) - Pangali P/E|Rasio rega marang bathi Helius Medical|Passage Bio, Inc. - Kapitalisasi marang bathi resik|Koefisien rega marang bathi NEUP (Neuphoria)|NERV - Kapitalisasi marang bathi|Pangali P/E ATHA (athira.com)|Pangali P/E Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - Pangali P/E|CYCN - Pangali P/E|PTIX (Protagenic Therapeutics, Inc.) - Koefisien rega marang bathi|Kapitalisasi marang bathi Pasithea (KTTA)|Rasio rega marang bathi Cortigent|Kapitalisasi marang bathi Avenue Therapeutics Inc. ATXI|Rasio rega marang bathi brainstorm-cell.com (BCLI)|Koefisien rega marang bathi Cara Therapeutics, Inc CARA|Pangali P/E CHRO (chromocell.com)|Nilai perusahaan marang bathi resik ELYM|Intra-Cellular Therapies Inc. - Pangali P/E|Kapitalisasi marang bathi Longboard Pharmaceuticals Inc|Marinus (MRNS) - Rasio rega marang bathi|NKGN - Periode bali modal bisnis|Rasio rega marang bathi NeuroBo Pharmaceuticals|SAGE: Nilai perusahaan marang bathi resik|Pangali P/E SNPX|Trevena Inc. - Pangali rega marang bathi|Rasio rega marang bathi Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Rasio rega marang bathi|Cerevel Therapeutics - Pangali P/E
